Cite
452 - Early Fluid Overload is a Serious Toxicity Associated with an Increased Risk of Non-Relapse Mortality after Ex-Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation.
MLA
Rondon-Clavo, Carlos, et al. “452 - Early Fluid Overload Is a Serious Toxicity Associated with an Increased Risk of Non-Relapse Mortality after Ex-Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation.” Biology of Blood & Marrow Transplantation, vol. 24, Mar. 2018, pp. S314–16. EBSCOhost, https://doi.org/10.1016/j.bbmt.2017.12.364.
APA
Rondon-Clavo, C., Scordo, M., Hilden, P., Shah, G. L., Cho, C., Maloy, M., Papadopoulos, E. B., Jakubowski, A. A., O’Reilly, R. J., Gyurkocza, B., Castro-Malaspina, H., Tamari, R., Shaffer, B. C., Perales, M.-A., Jaimes, E. A., & Giralt, S. A. (2018). 452 - Early Fluid Overload is a Serious Toxicity Associated with an Increased Risk of Non-Relapse Mortality after Ex-Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation. Biology of Blood & Marrow Transplantation, 24, S314–S316. https://doi.org/10.1016/j.bbmt.2017.12.364
Chicago
Rondon-Clavo, Carlos, Michael Scordo, Patrick Hilden, Gunjan L. Shah, Christina Cho, Molly Maloy, Esperanza B. Papadopoulos, et al. 2018. “452 - Early Fluid Overload Is a Serious Toxicity Associated with an Increased Risk of Non-Relapse Mortality after Ex-Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation.” Biology of Blood & Marrow Transplantation 24 (March): S314–16. doi:10.1016/j.bbmt.2017.12.364.